- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x EUJ: (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dioctanoate(Non-covalent)
EUJ.5: 13 residues within 4Å:- Chain A: Y.95, K.103, K.107, R.109, C.112, K.113, L.359, L.362, L.363, R.366, S.367, R.370, Y.403
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:L.359, A:L.362, A:L.363
- Hydrogen bonds: A:Y.95, A:K.103, A:C.112, A:K.113, A:R.366
- Salt bridges: A:K.103, A:K.107, A:R.109, A:K.113, A:K.113, A:R.366, A:R.370
EUJ.18: 13 residues within 4Å:- Chain B: Y.95, K.103, K.107, R.109, C.112, K.113, L.359, L.362, L.363, R.366, S.367, R.370, Y.403
17 PLIP interactions:17 interactions with chain B- Hydrophobic interactions: B:L.359, B:L.362, B:L.363
- Hydrogen bonds: B:Y.95, B:K.103, B:C.112, B:K.113, B:R.366, B:S.367, B:S.367
- Salt bridges: B:K.103, B:K.107, B:R.109, B:K.113, B:K.113, B:R.366, B:R.370
EUJ.30: 13 residues within 4Å:- Chain C: Y.95, K.103, K.107, R.109, C.112, K.113, L.359, L.362, L.363, R.366, S.367, R.370, Y.403
15 PLIP interactions:15 interactions with chain C- Hydrophobic interactions: C:L.359, C:L.362, C:L.363
- Hydrogen bonds: C:Y.95, C:K.103, C:C.112, C:K.113, C:R.366
- Salt bridges: C:K.103, C:K.107, C:R.109, C:K.113, C:K.113, C:R.366, C:R.370
EUJ.43: 13 residues within 4Å:- Chain D: Y.95, K.103, K.107, R.109, C.112, K.113, L.359, L.362, L.363, R.366, S.367, R.370, Y.403
15 PLIP interactions:15 interactions with chain D- Hydrophobic interactions: D:L.359, D:L.362, D:L.363
- Hydrogen bonds: D:Y.95, D:K.103, D:C.112, D:K.113, D:R.366
- Salt bridges: D:K.103, D:K.107, D:R.109, D:K.113, D:K.113, D:R.366, D:R.370
- 12 x HEX: HEXANE(Non-covalent)(Non-functional Binders)
HEX.6: 2 residues within 4Å:- Chain A: I.129
- Ligands: HEX.7
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:I.129
HEX.7: 2 residues within 4Å:- Ligands: HEX.6, PLC.52
No protein-ligand interaction detected (PLIP)HEX.8: 2 residues within 4Å:- Chain A: C.101, Y.452
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:Y.452
HEX.19: 1 residues within 4Å:- Ligands: HEX.20
No protein-ligand interaction detected (PLIP)HEX.20: 2 residues within 4Å:- Ligands: PLC.14, HEX.19
No protein-ligand interaction detected (PLIP)HEX.21: 2 residues within 4Å:- Chain B: C.101, Y.452
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Y.452
HEX.31: 2 residues within 4Å:- Chain C: I.129
- Ligands: HEX.32
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:I.129
HEX.32: 2 residues within 4Å:- Ligands: PLC.27, HEX.31
No protein-ligand interaction detected (PLIP)HEX.33: 2 residues within 4Å:- Chain C: C.101, Y.452
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:Y.452
HEX.44: 2 residues within 4Å:- Chain D: I.129
- Ligands: HEX.45
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:I.129
HEX.45: 2 residues within 4Å:- Ligands: PLC.39, HEX.44
No protein-ligand interaction detected (PLIP)HEX.46: 2 residues within 4Å:- Chain D: C.101, Y.452
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:Y.452
- 4 x D12: DODECANE(Non-covalent)
D12.9: 4 residues within 4Å:- Chain A: M.474, R.475, C.478
- Chain B: Y.459
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:M.474
D12.22: 4 residues within 4Å:- Chain B: M.474, R.475, C.478
- Chain C: Y.459
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:M.474
D12.34: 4 residues within 4Å:- Chain C: M.474, R.475, C.478
- Chain D: Y.459
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:M.474
D12.47: 4 residues within 4Å:- Chain A: Y.459
- Chain D: M.474, R.475, C.478
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:M.474
- 12 x D10: DECANE(Non-functional Binders)(Non-covalent)
D10.10: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)D10.11: 2 residues within 4Å:- Chain A: S.415, M.419
No protein-ligand interaction detected (PLIP)D10.12: 4 residues within 4Å:- Chain A: V.399, G.401, W.402
- Ligands: 8K6.42
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:W.402
D10.23: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)D10.24: 2 residues within 4Å:- Chain B: S.415, M.419
No protein-ligand interaction detected (PLIP)D10.25: 4 residues within 4Å:- Chain B: V.399, G.401, W.402
- Ligands: 8K6.16
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:W.402
D10.35: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)D10.36: 2 residues within 4Å:- Chain C: S.415, M.419
No protein-ligand interaction detected (PLIP)D10.37: 4 residues within 4Å:- Chain C: V.399, G.401, W.402
- Ligands: 8K6.28
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:W.402
D10.48: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)D10.49: 2 residues within 4Å:- Chain D: S.415, M.419
No protein-ligand interaction detected (PLIP)D10.50: 4 residues within 4Å:- Chain D: V.399, G.401, W.402
- Ligands: 8K6.40
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:W.402
- 4 x OCT: N-OCTANE(Non-covalent)
OCT.13: 2 residues within 4Å:- Chain A: F.456, Y.459
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.456, A:F.456
OCT.26: 2 residues within 4Å:- Chain B: F.456, Y.459
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:F.456, B:F.456
OCT.38: 2 residues within 4Å:- Chain C: F.456, Y.459
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:F.456, C:F.456
OCT.51: 2 residues within 4Å:- Chain D: F.456, Y.459
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:F.456, D:F.456
- 4 x PLC: DIUNDECYL PHOSPHATIDYL CHOLINE(Non-covalent)
PLC.14: 14 residues within 4Å:- Chain A: W.492, R.503, S.504, L.505, S.506, S.509
- Chain B: L.133
- Chain D: Q.532, W.539, L.540, Q.543, Y.547
- Ligands: 01.15, HEX.20
7 PLIP interactions:3 interactions with chain A, 4 interactions with chain D- Hydrogen bonds: A:L.505, A:S.506, A:S.506, D:Q.532
- Hydrophobic interactions: D:W.539, D:Y.547, D:Y.547
PLC.27: 14 residues within 4Å:- Chain A: Q.532, W.539, L.540, Q.543, Y.547
- Chain B: W.492, R.503, S.504, L.505, S.506, S.509
- Chain C: L.133
- Ligands: 01.17, HEX.32
7 PLIP interactions:3 interactions with chain B, 4 interactions with chain A- Hydrogen bonds: B:L.505, B:S.506, B:S.506, A:Q.532
- Hydrophobic interactions: A:W.539, A:Y.547, A:Y.547
PLC.39: 15 residues within 4Å:- Chain B: Q.532, W.539, L.540, Q.543, Y.547
- Chain C: W.492, R.503, S.504, L.505, S.506, S.509
- Chain D: L.133, Q.136
- Ligands: 01.29, HEX.45
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain B- Hydrogen bonds: C:L.505, C:S.506, C:S.506, B:Q.532
- Hydrophobic interactions: B:W.539, B:Y.547, B:Y.547
PLC.52: 15 residues within 4Å:- Chain A: L.133
- Chain C: Q.532, W.539, L.540, Q.543, L.544, Y.547
- Chain D: W.492, R.503, S.504, L.505, S.506, S.509
- Ligands: HEX.7, 01.41
8 PLIP interactions:5 interactions with chain C, 3 interactions with chain D- Hydrophobic interactions: C:W.539, C:L.544, C:Y.547, C:Y.547
- Hydrogen bonds: C:Q.532, D:L.505, D:S.506, D:S.506
- 4 x 01: N-[(1R,2R)-2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide
01.15: 17 residues within 4Å:- Chain A: V.473, M.474, C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.561
- Chain D: Y.547, S.548, S.551, L.552, Y.555, M.556
- Ligands: PLC.14
7 PLIP interactions:4 interactions with chain A, 3 interactions with chain D- Hydrophobic interactions: A:V.473, A:Y.484, A:I.516, A:F.561, D:Y.547, D:Y.555
- Hydrogen bonds: D:S.551
01.17: 17 residues within 4Å:- Chain A: Y.547, S.548, S.551, L.552, Y.555, M.556
- Chain B: V.473, M.474, C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.561
- Ligands: PLC.27
8 PLIP interactions:4 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:Y.547, A:Y.555, A:Y.555, B:V.473, B:Y.484, B:I.516, B:F.561
- Hydrogen bonds: A:S.551
01.29: 17 residues within 4Å:- Chain B: Y.547, S.548, S.551, L.552, Y.555, M.556
- Chain C: V.473, M.474, C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.561
- Ligands: PLC.39
7 PLIP interactions:4 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:V.473, C:Y.484, C:I.516, C:F.561, B:Y.547, B:Y.555
- Hydrogen bonds: B:S.551
01.41: 17 residues within 4Å:- Chain C: Y.547, S.548, S.551, L.552, Y.555, M.556
- Chain D: V.473, M.474, C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.561
- Ligands: PLC.52
7 PLIP interactions:4 interactions with chain D, 3 interactions with chain C- Hydrophobic interactions: D:V.473, D:Y.484, D:I.516, D:F.561, C:Y.547, C:Y.555
- Hydrogen bonds: C:S.551
- 4 x 8K6: Octadecane(Non-covalent)
8K6.16: 14 residues within 4Å:- Chain A: I.483, Y.487, F.541, L.544, Y.545, S.548, L.552
- Chain B: W.402, L.443, V.447, I.450, I.463, R.467
- Ligands: D10.25
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:I.483, A:L.544, B:L.443, B:I.450, B:I.463, B:R.467
8K6.28: 14 residues within 4Å:- Chain B: I.483, Y.487, F.541, L.544, Y.545, S.548, L.552
- Chain C: W.402, L.443, V.447, I.450, I.463, R.467
- Ligands: D10.37
6 PLIP interactions:2 interactions with chain B, 4 interactions with chain C- Hydrophobic interactions: B:I.483, B:L.544, C:L.443, C:I.450, C:I.463, C:R.467
8K6.40: 14 residues within 4Å:- Chain C: I.483, Y.487, F.541, L.544, Y.545, S.548, L.552
- Chain D: W.402, L.443, V.447, I.450, I.463, R.467
- Ligands: D10.50
6 PLIP interactions:2 interactions with chain C, 4 interactions with chain D- Hydrophobic interactions: C:I.483, C:L.544, D:L.443, D:V.447, D:I.450, D:R.467
8K6.42: 14 residues within 4Å:- Chain A: W.402, L.443, V.447, I.450, I.463, R.467
- Chain D: I.483, Y.487, F.541, L.544, Y.545, S.548, L.552
- Ligands: D10.12
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain D- Hydrophobic interactions: A:L.443, A:I.450, A:I.463, A:R.467, D:I.483, D:L.544
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reeks, J. et al., Enabling High Throughput Electron Cryo-microscopy for Structure-based Design. To Be Published
- Release Date
- 2025-06-04
- Peptides
- Mucolipin-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x EUJ: (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dioctanoate(Non-covalent)
- 12 x HEX: HEXANE(Non-covalent)(Non-functional Binders)
- 4 x D12: DODECANE(Non-covalent)
- 12 x D10: DECANE(Non-functional Binders)(Non-covalent)
- 4 x OCT: N-OCTANE(Non-covalent)
- 4 x PLC: DIUNDECYL PHOSPHATIDYL CHOLINE(Non-covalent)
- 4 x 01: N-[(1R,2R)-2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide
- 4 x 8K6: Octadecane(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reeks, J. et al., Enabling High Throughput Electron Cryo-microscopy for Structure-based Design. To Be Published
- Release Date
- 2025-06-04
- Peptides
- Mucolipin-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.